SEATTLE, March 17, 2025 /PRNewswire/ -- Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the successful completion of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results